Incidence and Predictors of Late Complete Heart Block After Alcohol Septal Ablation Treatment of Hypertrophic Obstructive Cardiomyopathy

被引:12
|
作者
Schuller, Joseph L. [1 ,2 ]
Zipse, Matthew M. [1 ]
Krantz, Mori J. [1 ,2 ]
Blaker, Brian [1 ]
Salcedo, Ernesto [1 ]
Groves, Bertron M. [1 ]
Messenger, John C. [1 ]
Beaty, Brenda [2 ,3 ]
Sauer, William H. [1 ]
机构
[1] Denver Hlth, Div Cardiol, Denver, CO USA
[2] Univ Colorado, Sch Med, Aurora, CO USA
[3] Colorado Hlth Outcomes Program, Aurora, CO USA
关键词
FOLLOW-UP; TRANSCORONARY ABLATION; MYOCARDIAL ABLATION; DELAYED OCCURRENCE; MYECTOMY; REDUCTION; BAYLOR; COLLAGEN; THERAPY;
D O I
10.1111/joic.12178
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectivesThis study was designed to identify the incidence of late complete heart block (CHB) first identified at least 48hours post alcohol septal ablation (ASA). BackgroundSeptal reduction with ASA is a therapeutic option for patients with symptomatic hypertrophic obstructive cardiomyopathy (HCM). CHB, resulting from the septal infarct, is a known complication with a reported incidence of 9-22%. The incidence of CHB more than 48hours post-procedure is unknown. MethodsConsecutive patients who underwent ASA were analyzed and clinical characteristics associated with late CHB were assessed. Late CHB was defined as first identification of CHB more than 48hours after ASA. ResultsFrom 2002-2013, 145 subjects underwent 168 ASA procedures and were followed for a mean of 3.2 +/- 2.3 years. The incidence of late CHB was 8.9% (15/168 ASA procedures). Heart block occurred from 48hours to 3-years post-procedure. In a multivariable model, patients with any CHB were more likely to have had multiple ASA procedures (OR 4.14; 95% CI: 1.24, 13.9; P<0.05) and high resting and provoked left ventricular outflow tract (LVOT) gradient assessed by catheterization (OR per 10mmHg gradient 1.14; 95% CI: 1.0, 1.20; P<0.05). After multivariable adjustment, only a high provokable LVOT gradient remained an independent predictor of late CHB (OR per 10mmHg gradient 1.14 [95% CI 1.02-1.29]). ConclusionsLate CHB is a common complication of ASA for treatment of symptomatic HCM. Post-discharge electrocardiographic surveillance for atrioventricular conduction disease should be considered after ASA, especially for those with a high provokable LVOT gradient. (J Interven Cardiol 2015;28:90-97)
引用
收藏
页码:90 / 97
页数:8
相关论文
共 50 条
  • [1] Survival After Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy
    Sorajja, Paul
    Ommen, Steve R.
    Holmes, David R., Jr.
    Dearani, Joseph A.
    Rihal, Charanjit S.
    Gersh, Bernard J.
    Lennon, Ryan J.
    Nishimura, Rick A.
    CIRCULATION, 2012, 126 (20) : 2374 - 2380
  • [2] Atrioventricular conduction after alcohol septal ablation for obstructive hypertrophic cardiomyopathy
    Axelsson, Anna
    Weibring, Kristina
    Havndrup, Ole
    Kelbaek, Henning
    Jorgensen, Erik
    Helqvist, Steffen
    Iversen, Kasper
    Kober, Lars
    Bundgaard, Henning
    Jensen, Morten Kvistholm
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2014, 15 (03) : 214 - 221
  • [3] Septal alcohol ablation in hypertrophic obstructive cardiomyopathy: A retrospective analysis
    Yavuzgil, Oguz
    Tuluce, Kamil
    Simsek, Evrim
    Gurgun, Cemil
    Kultursay, Hakan
    Payzin, Serdar
    Hasdemir, Can
    Can, Levent Hurkan
    Turkoglu, Cuneyt
    TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2012, 20 (03): : 427 - 433
  • [4] Alcohol dose in septal ablation for hypertrophic obstructive cardiomyopathy
    Veselka, Josef
    Faber, Lothar
    Liebregts, Max
    Cooper, Robert
    Januska, Jaroslav
    Kashtanov, Maksim
    Dabrowski, Maciej
    Hansen, Peter Riis
    Seggewiss, Hubert
    Bonaventura, Jiri
    Polakova, Eva
    Hansvenclova, Eva
    Bundgaard, Henning
    ten Berg, Jurrien
    Stables, Rodney Hilton
    Jarkovsky, Jiri
    Jensen, Morten Kvistholm
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 333 : 127 - 132
  • [5] Alcohol Septal Ablation for the Treatment of Hypertrophic Obstructive Cardiomyopathy A Multicenter North American Registry
    Nagueh, Sherif F.
    Groves, Bertron M.
    Schwartz, Leonard
    Smith, Karen M.
    Wang, Andrew
    Bach, Richard G.
    Nielsen, Christopher
    Leya, Ferdinand
    Buergler, John M.
    Rowe, Steven K.
    Woo, Anna
    Maldonado, Yolanda Munoz
    Spencer, William H., III
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (22) : 2322 - 2328
  • [6] Predicting complete heart block after alcohol septal ablation for hypertrophic cardiomyopathy using a risk stratification model and clinical tool
    Karimianpour, Ahmadreza
    Heizer, Justin
    Leaphart, Davis
    Rier, Jeremy D.
    Shaji, Shawn
    Ramakrishnan, Viswanathan
    Nielsen, Christopher D.
    Fernandes, Valerian L.
    Gold, Michael R.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2021, 98 (02) : 393 - 400
  • [7] Alcohol septal ablation for the treatment of obstructive hypertrophic cardiomyopathy: A demanding option
    Brito, Dulce
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2014, 33 (01) : 11 - 13
  • [8] Alcohol Septal Ablation or Mavacamten for Obstructive Hypertrophic Cardiomyopathy
    Scholtz, Smita
    Rudolph, Volker
    Reil, Jan-Christian
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (20)
  • [9] Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy
    Rigopoulos, Angelos G.
    Panou, Fotios
    Kremastinos, Dimitrios Th.
    Seggewiss, Hubert
    HELLENIC JOURNAL OF CARDIOLOGY, 2009, 50 (06) : 511 - 522
  • [10] Low Incidence of Procedure-Related Major Adverse Cardiac Events After Alcohol Septal Ablation for Symptomatic Hypertrophic Obstructive Cardiomyopathy
    Veselka, Josef
    Lawrenz, Thorsten
    Stellbrink, Christoph
    Zemanek, David
    Branny, Marian
    Januska, Jaroslav
    Groch, Ladislav
    Dimitrow, Pawel
    Krejci, Jan
    Dabrowski, Maciej
    Mizera, Stanislav
    Kuhn, Horst
    CANADIAN JOURNAL OF CARDIOLOGY, 2013, 29 (11) : 1415 - 1421